Fig. 2
From: Revealing multiple biological subtypes of schizophrenia through a data-driven approach
Differences between the two brain subtypes and their corresponding biomarkers. (a) Comparison of differences in GMV, WMV, ALFF, and ReHo (dGMV, dGMV, dALFF, and dReHo) between BS1 patients and HCs. (b) Comparison of dGMV, dGMV, dALFF, and dReHo between BS2 patients and HCs. (c) Differences in the network features of the clustering coefficient and global efficiency between BSs and HCs. *pBonferroni< 0.05, **pBonferroni< 0.01, ***pBonferroni< 0.001. (d) Abnormal brain FC in BSs compared with HCs. (e) Brain FC abnormalities in BSs and the networks in which they reside are shown and compared with HCs. (f) Differences in clinical symptoms and cognitive performance between BSs and HCs (data are normalized), where P, N, G, and T represent PANSS PScore, NScore, GScore, TScore, respectively. M1-M5 and M represent processing speed, attention/vigilance, working memory, verbal learning, visual learning, and total scores of the first five dimensions of the MCCB, respectively. ●pall< 0.05 and ○pBSs< 0.05 (with Bonferroni correction); all values are displayed in Supplemental Table S4. (g) Biomarkers of the PANSS and MCCB scores of BS1 patients. (h) Biomarkers of the PANSS scores of BS2 patients. The error bands in figures (g-h) represent 95% confidence interval